On site generated performic acid compositions for teat treatment

US11771673B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11771673-B2
Application numberUS-202117448311-A
CountryUS
Kind codeB2
Filing dateSep 21, 2021
Priority dateJun 15, 2018
Publication dateOct 3, 2023
Grant dateOct 3, 2023

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

The present disclosure relates generally to peroxyformic acid forming compositions and methods for forming peroxyformic acid, preferably in situ, and peroxyformic acid formed by said compositions and methods for the purpose of treating an animal tissue and providing an antimicrobial function thereon. present disclosure in particular relates to a residue-free teat treatment composition for the treatment of an animal tissue, especially bovine teats, which provides antimicrobial efficacy and does not leave a non-food ingredient residue on treated teats.

First claim

Opening claim text (preview).

The claimed invention is: 1. A method of preventing and/or treating mastitis comprising: applying an antimicrobial teat dip composition to an animal tissue; wherein the antimicrobial teat dip composition comprises hydrogen peroxide or a hydrogen peroxide forming compound; an ester of an alcohol and formic acid; a dye, wherein the dye is red #40, yellow #5, yellow #6, or a mixture thereof; and water; and wherein the pH of the antimicrobial teat dip composition is between about 2 and about 7; wherein the dye results in the coloring of a teat without interfering with the antimicrobial function of the composition; and removing the antimicrobial teat dip composition from the animal tissue. 2. The method of claim 1 , wherein the ester of an alcohol and formic acid comprises a glycerol formate, an ethylene glycol formate, a pentaerythritol formate, a mannitol formate, a propylene glycol formate, a sorbitol formate, a sugar formate, a methyl formate, an ethyl formate, a propyl formate, a butyl formate, a heptyl formate, a pentyl formate, a benzyl formate, or a mixture thereof. 3. The method of claim 2 , wherein the sugar formate is a glycerol formate, a sucrose formate, a dextrin formate, a maltodextrin formate, a starch formate, or a mixture thereof. 4. The method of claim 1 , wherein the antimicrobial teat dip composition provides a 4-log reduction in Staphylococcus aureus and Escherichia coli. 5. The method of claim 1 , further comprising an emollient, a medicament, a foaming surfactant, a buffering agent, a stabilizing agent, or a combination thereof. 6. The method of claim 5 , wherein the emollient comprises glycerin, glycerol, propylene glycol, dipropylene glycol, sorbitol, aloe, shea butter, coco butter, allantoin, or a mixture thereof; wherein the stabilizing agent comprises a phosphonate, a dicarboxylic acid, a pyridine carboxylic acid, or a mixture thereof; wherein the buffering agent comprises succinic acid or a salt thereof; and wherein the foaming surfactant is polysorbate and/or dioctyl sulfosuccinate sodium salt. 7. The method of claim 5 , wherein the medicament comprises paraamino benzoic acid, allantoin, urea, or a mixture thereof. 8. The method of claim 1 , wherein the composition comprises between about 90.0 wt. % and about 99.9 wt. % water, between about 50 ppm and about 2 wt. % of hydrogen peroxide or a hydrogen peroxide forming compound, between about 50 ppm and about 350 ppm of performic acid; and wherein the composition is stable for at least 24 hours. 9. The method of claim 1 , wherein the animal tissue is a bovine teat. 10. A method of preventing and/or treating mastitis comprising: diluting an antimicrobial teat dip composition to form a ready-to-use teat dip composition; wherein the antimicrobial teat dip composition comprises hydrogen peroxide or a hydrogen peroxide forming compound; an ester of an alcohol and formic acid; a dye, wherein the dye is red #40, yellow #5, yellow #6, or a mixture thereof; and water; and wherein the pH of the antimicrobial teat dip composition is between about 2 and about 7; applying the ready-to-use teat dip composition to an animal tissue; wherein the dye results in the coloring of a teat without interfering with the antimicrobial function of the composition; and removing the ready-to-use teat dip composition from the animal tissue. 11. The method of claim 10 , wherein the ester of an alcohol and formic acid comprises a glycerol formate, an ethylene glycol formate, a pentaerythritol formate, a mannitol formate, a propylene glycol formate, a sorbitol formate, a sugar formate, a methyl formate, an ethyl formate, a propyl formate, a butyl formate, a heptyl formate, a pentyl formate, a benzyl formate, or a mixture thereof. 12. The method of claim 11 , wherein the sugar formate is a glycerol formate, a sucrose formate, a dextrin formate, a maltodextrin formate, a starch formate, or a mixture thereof. 13. The method of claim 10 , wherein the antimicrobial teat dip composition provides a 4-log reduction in Staphylococcus aureus and Escherichia coli. 14. The method of claim 10 , further comprising an emollient, a medicament, a foaming surfactant, a buffering agent, a stabilizing agent, or a combination thereof. 15. The method of claim 14 , wherein the emollient comprises glycerin, glycerol, propylene glycol, dipropylene glycol, sorbitol, aloe, shea butter, coco butter, allantoin, or a mixture thereof; wherein the stabilizing agent comprises a phosphonate, a dicarboxylic acid, a pyridine carboxylic acid, or a mixture thereof; wherein the buffering agent comprises succinic acid or a salt thereof; and wherein the foaming surfactant is polysorbate and/or dioctyl sulfosuccinate sodium salt. 16. The method of claim 14 , wherein the medicament comprises paraamino benzoic acid, allantoin, urea, or a mixture thereof. 17. The method of claim 10 , wherein the animal tissue is a bovine teat. 18. The method of claim 10 , wherein the antimicrobial teat dip composition comprises between about 50 wt. % and about 99 wt. % water, and between about 0.1 wt. % and about 20 wt. % of hydrogen peroxide or a hydrogen peroxide forming compound. 19. The method of claim 10 , wherein the ready-to-use teat dip composition comprises between about 90.0 wt. % and about 99.9 wt. % water, between about 50 ppm and about 2 wt. % of hydrogen peroxide or a hydrogen peroxide forming compound, between about 50 ppm and about 350 ppm of performic acid; and wherein the composition is stable for at least 24 hours. 20. The method of claim 10 , further comprising the step of combining a first premix and a second premix to form the antimicrobial teat dip composition; wherein the first premix comprises the ester of the alcohol and formic acid; wherein the second premix comprises the hydrogen peroxide or the hydrogen peroxide forming compound and the dye. 21. The method of claim 1 , wherein the antimicrobial teat dip composition is removed from the animal tissue after at least 1 minute of contact. 22. The method of claim 10 , wherein the ready-to-use teat dip composition is removed from the animal tissue after at least 1 minute of contact.

Assignees

Inventors

Classifications

  • A61K31/22Primary

    of acyclic acids, e.g. pravastatin · CPC title

  • Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers · CPC title

  • A01N37/16Primary

    containing the group [IMAGE cpc-sch-A01N-0934.gif]; Thio analogues thereof · CPC title

  • Peroxides · CPC title

  • Non-human animal skin, e.g. pour-on, spot-on · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11771673B2 cover?
The present disclosure relates generally to peroxyformic acid forming compositions and methods for forming peroxyformic acid, preferably in situ, and peroxyformic acid formed by said compositions and methods for the purpose of treating an animal tissue and providing an antimicrobial function thereon. present disclosure in particular relates to a residue-free teat treatment composition for the t…
Who is the assignee on this patent?
Ecolab Usa Inc
What technology area does this patent fall under?
Primary CPC classification A61K31/22. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Oct 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 12 related publications on this page (citations in our corpus or others sharing the same primary CPC).